Annual report [Section 13 and 15(d), not S-K Item 405]

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

v3.25.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Adoption of ASU 2016-13
After Adoption of ASU 2016-13
Common Stock
Common Stock
After Adoption of ASU 2016-13
Additional Paid-In Capital
Additional Paid-In Capital
After Adoption of ASU 2016-13
Accumulated Deficit
Accumulated Deficit
Adoption of ASU 2016-13
Accumulated Deficit
After Adoption of ASU 2016-13
Beginning Balance at Dec. 31, 2022 $ 102,624 $ (632) $ 101,992 $ 11,591 $ 11,591 $ 107,372 $ 107,372 $ (16,339) $ (632) $ (16,971)
Beginning Balance (in shares) at Dec. 31, 2022       15,973 15,973          
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) (24,402)             (24,402)    
Vesting of restricted stock (482)     $ (48)   (434)        
Vesting of restricted stock (in shares)       315            
Stock-based compensation expense 1,991     $ 199   1,792        
Repurchases of common stock (128)     $ (13)   (115)        
Repurchases of common stock (in shares)       (30)            
Ending Balance at Dec. 31, 2023 $ 78,971     $ 11,729   108,615   (41,373)    
Ending Balance (in shares) at Dec. 31, 2023 16,258     16,258            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) $ 14,741             14,741    
Vesting of restricted stock (1,183)     $ (118)   (1,065)        
Vesting of restricted stock (in shares)       319            
Stock-based compensation expense 1,777     $ 178   1,599        
Repurchases of common stock (1,204)     $ (120)   (1,084)        
Repurchases of common stock (in shares)       (231)            
Ending Balance at Dec. 31, 2024 $ 93,102     $ 11,669   $ 108,065   $ (26,632)    
Ending Balance (in shares) at Dec. 31, 2024 16,346     16,346